Literature DB >> 1370546

Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1.

P L Boyer1, A L Ferris, S H Hughes.   

Abstract

We constructed a series of BspMI cassettes that simplify the introduction of specific point mutations in the polymerase domain of human immunodeficiency virus type 1 reverse transcriptase. A series of point mutants were constructed by using these cassette vectors. The RNA-dependent DNA polymerase and RNase H activities of 20 point mutations in the conserved portion of the polymerase domain were assayed. All the mutations analyzed are conservative substitutions of evolutionarily conserved amino acids. The mutations were divided into four classes. The first class has little effect on either polymerase or RNase H activity. The second class affects RNase H but not polymerase activity, while the third class has a normal RNase H activity with diminished polymerase activity. The fourth class affects both activities.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370546      PMCID: PMC240806     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Purification and characterization of the RNase H domain of HIV-1 reverse transcriptase expressed in recombinant Escherichia coli.

Authors:  S P Becerra; G M Clore; A M Gronenborn; A R Karlström; S J Stahl; S H Wilson; P T Wingfield
Journal:  FEBS Lett       Date:  1990-09-17       Impact factor: 4.124

Review 2.  HIV-1 reverse transcriptase: structure predictions for the polymerase domain.

Authors:  A M Barber; A Hizi; J V Maizel; S H Hughes
Journal:  AIDS Res Hum Retroviruses       Date:  1990-09       Impact factor: 2.205

3.  p21-ras effector domain mutants constructed by "cassette" mutagenesis.

Authors:  J C Stone; W C Vass; B M Willumsen; D R Lowy
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

4.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Point mutations in conserved amino acid residues within the C-terminal domain of HIV-1 reverse transcriptase specifically repress RNase H function.

Authors:  O Schatz; F V Cromme; F Grüninger-Leitch; S F Le Grice
Journal:  FEBS Lett       Date:  1989-11-06       Impact factor: 4.124

6.  Evidence from direct visualization after denaturing gel electrophoresis that RNase H is associated with MSV-MuLV reverse transcripase.

Authors:  M Rucheton; M N Lelay; P Jeanteur
Journal:  Virology       Date:  1979-08       Impact factor: 3.616

7.  Site-directed mutagenesis of the conserved Asp-443 and Asp-498 carboxy-terminal residues of HIV-1 reverse transcriptase.

Authors:  V Mizrahi; M T Usdin; A Harington; L R Dudding
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

8.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

9.  HIV-1 reverse transcriptase purified from a recombinant strain of Escherichia coli.

Authors:  P K Clark; A L Ferris; D A Miller; A Hizi; K W Kim; S M Deringer-Boyer; M L Mellini; A D Clark; G F Arnold; W B Lebherz
Journal:  AIDS Res Hum Retroviruses       Date:  1990-06       Impact factor: 2.205

10.  Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.

Authors:  A Hizi; R Tal; S H Hughes
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

View more
  62 in total

1.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

2.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.

Authors:  Z Sevilya; S Loya; N Adir; A Hizi
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

4.  Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; Edward Arnold; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

5.  Characterization of the double stranded RNA dependent RNase activity associated with recombinant reverse transcriptases.

Authors:  H Ben-Artzi; E Zeelon; S F Le-Grice; M Gorecki; A Panet
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

6.  Sequence similarity between Borna disease virus p40 and a duplicated domain within the paramyxovirus and rhabdovirus polymerase proteins.

Authors:  M A McClure; K J Thibault; C G Hatalski; W I Lipkin
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  Specific inhibition of the reverse transcriptase of human immunodeficiency virus type 1 and the chimeric enzymes of human immunodeficiency virus type 1 and type 2 by nonnucleoside inhibitors.

Authors:  A Hizi; R Tal; M Shaharabany; M J Currens; M R Boyd; S H Hughes; J B McMahon
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Purification and characterization of an active human immunodeficiency virus type 1 RNase H domain.

Authors:  J S Smith; M J Roth
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Analysis of nonnucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; M J Currens; J B McMahon; M R Boyd; S H Hughes
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.

Authors:  M Tisdale; S D Kemp; N R Parry; B A Larder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.